Concord Biotech Updates Key Managerial Personnel for Materiality Disclosures
Concord Biotech Limited has announced modifications to its Key Managerial Personnel (KMP) list responsible for determining the materiality of events or information and making disclosures to the stock ...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Concord Biotech Limited in the news today?
Concord Biotech Limited (CONCORDBIO) is in the news due to the announcement is a routine update regarding changes in key managerial personnel for disclosure purposes and does not inherently carry positive or negative financial implications.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Concord Biotech Updates Key Managerial Personnel for Materiality Disclosures
December 18, 2025, 08:24 AM
Concord Biotech Limited has announced modifications to its Key Managerial Personnel (KMP) list responsible for determining the materiality of events or information and making disclosures to the stock exchanges. The revised list includes Mr. Sudhir Vaid as Chairman and Managing Director, Mr. Ankur Vaid as Joint Managing Director and Chief Executive Officer, Mr. Raviraj Karia as Chief Financial Officer, and Ms. Hina Patel as Company Secretary and Compliance Officer.
Contact details for disclosures, including email and telephone number, have been provided for the compliance officer. This update is in accordance with Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
See What Deep Dive Gives You — in Seconds
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained - “Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap